Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gattringer

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Human Pathology|October 1, 1990
"Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two casesN Sepp, G Schuler, N Romani, et al.
Clinical and Experimental Immunology|August 1, 1989
Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviourR Stauder, R Greil, T F Schulz, et al.
Blut|March 1, 1985
Surface glycoproteins (S-GP) on normal and malignant human leukocytesE Leiter, R Pfister, D Lutz, et al.
Deutsche Medizinische Wochenschrift (1946)|May 10, 1991
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]J Thaler, T Kühr, G Gastl, et al.
International Journal of Cancer|October 15, 1988
abl oncogene expression in non-Hodgkin lymphomas: correlation to histological differentiation and clinical statusK Greil, C Gattringer, B Fasching, et al.
British Journal of Haematology|May 1, 1993
Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltrationJ Thaler, K Grünewald, C Gattringer, et al.
Leukemia Research|January 1, 1989
Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycinJ Thaler, H Denz, O Dietze, et al.
Leukemia|January 1, 1992
Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA GroupR Zittoun, V Liso, F Mandelli, et al.
Leukemia|January 1, 1992
Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA GroupR Zittoun, F Mandelli, R Willemze, et al.
Immunobiology|January 1, 1996
CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivoD Nachbaur, D Niederwieser, G Aichinger, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Human Pathology|October 1, 1990
"Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two casesN Sepp, G Schuler, N Romani, et al.
Clinical and Experimental Immunology|August 1, 1989
Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviourR Stauder, R Greil, T F Schulz, et al.
Blut|March 1, 1985
Surface glycoproteins (S-GP) on normal and malignant human leukocytesE Leiter, R Pfister, D Lutz, et al.
Deutsche Medizinische Wochenschrift (1946)|May 10, 1991
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]J Thaler, T Kühr, G Gastl, et al.
International Journal of Cancer|October 15, 1988
abl oncogene expression in non-Hodgkin lymphomas: correlation to histological differentiation and clinical statusK Greil, C Gattringer, B Fasching, et al.
British Journal of Haematology|May 1, 1993
Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltrationJ Thaler, K Grünewald, C Gattringer, et al.
Leukemia Research|January 1, 1989
Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycinJ Thaler, H Denz, O Dietze, et al.
Leukemia|January 1, 1992
Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA GroupR Zittoun, V Liso, F Mandelli, et al.
Leukemia|January 1, 1992
Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA GroupR Zittoun, F Mandelli, R Willemze, et al.
Immunobiology|January 1, 1996
CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivoD Nachbaur, D Niederwieser, G Aichinger, et al.
Pageof 7